Cargando…
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467142/ https://www.ncbi.nlm.nih.gov/pubmed/32879427 http://dx.doi.org/10.1038/s41375-020-01038-8 |
_version_ | 1783577955785506816 |
---|---|
author | Gozzetti, Alessandro Capochiani, Enrico Bocchia, Monica |
author_facet | Gozzetti, Alessandro Capochiani, Enrico Bocchia, Monica |
author_sort | Gozzetti, Alessandro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7467142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74671422020-09-03 The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 Gozzetti, Alessandro Capochiani, Enrico Bocchia, Monica Leukemia Correspondence Nature Publishing Group UK 2020-09-02 2020 /pmc/articles/PMC7467142/ /pubmed/32879427 http://dx.doi.org/10.1038/s41375-020-01038-8 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Correspondence Gozzetti, Alessandro Capochiani, Enrico Bocchia, Monica The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 |
title | The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 |
title_full | The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 |
title_fullStr | The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 |
title_full_unstemmed | The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 |
title_short | The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 |
title_sort | janus kinase 1/2 inhibitor ruxolitinib in covid-19 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467142/ https://www.ncbi.nlm.nih.gov/pubmed/32879427 http://dx.doi.org/10.1038/s41375-020-01038-8 |
work_keys_str_mv | AT gozzettialessandro thejanuskinase12inhibitorruxolitinibincovid19 AT capochianienrico thejanuskinase12inhibitorruxolitinibincovid19 AT bocchiamonica thejanuskinase12inhibitorruxolitinibincovid19 AT gozzettialessandro januskinase12inhibitorruxolitinibincovid19 AT capochianienrico januskinase12inhibitorruxolitinibincovid19 AT bocchiamonica januskinase12inhibitorruxolitinibincovid19 |